Crucell (CRXLY) Company Profile
Last Updated by Anonymous | Update This Page Now
Stage: Seed (just an idea)
Industry / Market
Growth Rate: n/a%
Other Info: n/a
Crucell N.V. is a biopharmaceutical company focused on developing and producing products to combat infectious diseases in three distinct areas: pediatric, travel and endemic, and respiratory. Crucells product development programs include vaccines against yellow fever, influenza, human immunodeficiency virus (HIV), malaria, tuberculosis, human monoclonal antibodies against rabies, H5N1 antibodies, pandemic influenza virus, as well as blood coagulation factors. (see report summary)
has a consistent company strategy. Big strategy changes can be disruptive, which could hurt long term value.